UGP2 and cancer: lncRNA SVUGP2 was significantly downregulated in β-catenin-positive fractions (∼0.72 folds; Figure 1C) which supports its reported repression in cancers through involvement of wnt- β-catenin signaling (Wei et al., 2019).